BMP-10 inhibitors are a class of chemical compounds that specifically target Bone Morphogenetic Protein 10 (BMP-10), a member of the TGF-β (transforming growth factor-beta) superfamily. BMP-10 plays a crucial role in regulating cellular processes such as differentiation, growth, and development, particularly in the context of cardiovascular and skeletal tissues. As a signaling molecule, BMP-10 is involved in activating specific signaling pathways that influence gene expression, promoting interactions with receptors on the surface of cells. Inhibitors of BMP-10 are designed to block its activity, preventing it from binding to its receptors or initiating downstream signaling events. This interference allows researchers to study the precise role of BMP-10 in various biological pathways, shedding light on how it contributes to tissue development and homeostasis.
BMP-10 inhibitors are small molecules or peptides that interact with either the ligand itself or its associated receptors. By binding to BMP-10 or its receptor sites, these inhibitors disrupt the normal signaling cascade that BMP-10 would trigger in target cells. This disruption is important for investigating the role BMP-10 plays in regulating cellular processes such as proliferation, differentiation, and extracellular matrix production. Researchers often use BMP-10 inhibitors to better understand how this protein influences developmental processes, particularly in the cardiovascular system and during organogenesis. These inhibitors are also valuable tools for exploring the broader TGF-β signaling pathways, as they help delineate the specific contributions of BMP-10 within these complex networks. Through controlled inhibition, scientists can explore how BMP-10 affects cellular communication and developmental regulation in various tissues.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
BML-275 (Dorsomorphin) may downregulate BMP-10 by directly antagonizing BMP type I receptors, thereby blocking the BMP signaling essential for BMP-10 mediated cellular processes. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline, also known as LDN-193189, could decrease BMP-10 expression by specifically inhibiting the kinase activity of BMP receptors, preventing SMAD1/5/8 phosphorylation, which is crucial for BMP-10 signal transduction. | ||||||
DMH-1 | 1206711-16-1 | sc-361171 sc-361171B sc-361171A sc-361171C | 10 mg 25 mg 50 mg 100 mg | $213.00 $318.00 $632.00 $1047.00 | 2 | |
By selectively targeting ALK2 and ALK3 within the BMP receptor complex, DMH-1 could reduce BMP-10 expression by disrupting the initial steps of the BMP-10 signaling cascade. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB 431542 may decrease the transcriptional activity of genes downstream of TGF-β signaling, including BMP-10, by inhibiting ALK4, ALK5, and ALK7 receptors. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK-506 (Tacrolimus) could downregulate BMP-10 by inhibiting calcineurin, leading to altered transcriptional responses in T-cells, which may extend to the expression of BMP-10. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A might decrease BMP-10 expression through calcineurin inhibition, similar to FK506, ultimately altering the immune cell-derived signals that control BMP-10 levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin might reduce BMP-10 expression by inhibiting mTORC1 signaling, which is implicated in the regulation of protein synthesis and cell growth, processes that BMP-10 is involved in. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid might inhibit the proliferation of certain immune cells that produce factors necessary for BMP-10 expression, leading to a decrease in BMP-10 levels. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide may downregulate BMP-10 by inhibiting the production of pro-inflammatory cytokines that can enhance BMP-10 expression in a paracrine fashion. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone could inhibit the expression of BMP-10 by antagonizing aldosterone receptors, which may play a role in the transcriptional control of the BMP-10 gene. | ||||||